Amicus Therapeutics, Inc. (FOLD)
14.33
+0.02
(+0.14%)
USD |
NASDAQ |
Jan 16, 16:00
14.32
-0.01
(-0.07%)
After-Hours: 20:00
Amicus Therapeutics Shareholders Equity (Quarterly): 230.42M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.057B |
| CorMedix, Inc. | 374.13M |
| Krystal Biotech, Inc. | 1.138B |
| ANI Pharmaceuticals, Inc. | 505.82M |
| Ekso Bionics Holdings, Inc. | 9.679M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 868.81M |
| Total Liabilities (Quarterly) | 638.39M |
| Debt to Equity Ratio | 1.922 |
| Current Ratio | 2.986 |
| Net Debt Paydown Yield | 0.01% |